SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company SOPHiA GENETICS’ next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees BOSTON and GENEVA, Switzerland, Sept. 21, 2022 (PR NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a …